Intelligent Bio Solutions (NASDAQ: INBS) reports 3,018,188 shares
Rhea-AI Filing Summary
Intelligent Bio Solutions Inc. reported that its total outstanding common stock was 3,018,188 shares as of the close of business on July 31, 2026. This updated share count reflects sales under an At The Market Offering Agreement, exercises of previously issued warrants, and issuances of restricted shares under an investor relations and corporate development advisory agreement.
Positive
- None.
Negative
- None.
Filing Explained
The reported common-share count increased from 1,216,142 on
8-K Event Classification
Item 8.01 — Other Events
1 item
Item 8.01
Other Events
Other
Voluntary disclosure of events the company deems important to shareholders but not covered by other items.
Key Figures
Shares outstanding: 3,018,188 shares
Par value per share: $0.01 per share
Commission File Number: 001-39825
+1 more
4 metrics
Shares outstanding
3,018,188 shares
Total common shares outstanding as of close of business on July 31, 2026
Par value per share
$0.01 per share
Par value of Intelligent Bio Solutions Inc. common stock
Commission File Number
001-39825
SEC registration file number for Intelligent Bio Solutions Inc.
IRS Employer Identification Number
82-1512711
Federal tax identification number of Intelligent Bio Solutions Inc.
Key Terms
At The Market Offering Agreement, warrants to purchase common stock, restricted common stock, Emerging growth company
4 terms
At The Market Offering Agreement financial
"pursuant to the previously disclosed At The Market Offering Agreement"
An at-the-market offering agreement is a contract that lets a company sell newly issued shares directly into the open market through a broker, at whatever price the stock is trading at that moment. For investors this matters because it can increase the number of shares available (which may dilute existing ownership) while providing a flexible, often faster way for the company to raise cash without fixing a price, similar to a vendor selling small batches at current market stalls rather than setting a single fixed price.
warrants to purchase common stock financial
"the exercise of previously disclosed outstanding warrants to purchase common stock"
restricted common stock financial
"the issuance of shares of restricted common stock pursuant to the agreement"
Restricted common stock is company shares that carry limits on selling or transferring for a set period or until certain conditions are met, like time-based vesting or regulatory clearance. Think of them as shares in a locked box that gradually open; they can become freely tradable later but initially reduce the number of shares available on the market. Investors watch restricted stock because its eventual release can change a company’s share supply, affect stock price, and influence control and dilution.
Emerging growth company regulatory
"405) or Rule 12b-2 of the Securities Exchange Act of 1934 Emerging growth company"
An emerging growth company is a recently public or smaller public firm that qualifies for temporary, lighter regulatory and disclosure rules to reduce the cost and effort of being public. For investors, it means the company may provide less historical financial detail and face fewer reporting requirements than larger firms, so it can grow more quickly but also carries higher uncertainty—like buying a promising early-stage product with fewer user reviews.
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
Which agreements affected INBS’s outstanding common stock total?
The share count was affected by an At The Market Offering Agreement with Ladenburg Thalmann & Co. Inc. and an Investor Relations and Corporate Development Advisory Agreement with ClearThink Capital Partners LLC, along with exercises of previously disclosed warrants.